$4.87
arrow_drop_up3.17%There's no data available for key stats
There's no data available for ratios/profitability stats
There's no data available for score breakdown
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
2seventy bio, Inc. (TSVT) Reports Q1 Loss, Tops Revenue Estimates
CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know
2seventy bio, Inc. (TSVT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?